{
    "organizations": [],
    "uuid": "8ebe75a9c93b9648173a140be320dd22f6c32edf",
    "author": "",
    "url": "https://www.reuters.com/article/brief-mylan-biocon-get-approvals-from-eu/brief-mylan-biocon-get-approvals-from-european-commission-tga-australia-for-semglee-biosimilar-insulin-glargine-idUSFWN1R90VX",
    "ord_in_thread": 0,
    "title": "BRIEF-Mylan, Biocon get approvals from European Commission, TGA Australia for Semglee, Biosimilar Insulin Glargine",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 27 (Reuters) - Mylan NV:\n* MYLAN AND BIOCON RECEIVE APPROVALS FROM THE EUROPEAN COMMISSION AND TGA AUSTRALIA FOR SEMGLEEâ„¢, BIOSIMILAR INSULIN GLARGINE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-28T06:07:00.000+03:00",
    "crawled": "2018-03-28T06:17:14.021+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "mylan",
        "nv",
        "mylan",
        "biocon",
        "receive",
        "approval",
        "european",
        "commission",
        "tga",
        "australia",
        "biosimilar",
        "insulin",
        "glargine",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}